Adjuvant Therapy for High-Risk Stage II Cutaneous Melanoma: Insights and Future Directions.

Cancers (Basel) · 2026 · PMC13256703 · PMID 42279384

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although perioperative pembrolizumab reduced sentinel node positivity by 18% overall, the reduction did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.